SelectScience InterviewsClinical Diagnostics

Experience ADLM 2024 with SelectScience

29 Aug 2024
Dora Wells
Clinical Content Editor
Experience ADLM 2024 with SelectScience

Dora Wells, our Clinical Content Editor at SelectScience, had the privilege of engaging with industry leaders at ADLM 2024.

During the event, we explored groundbreaking innovations, such as the Atellica portfolio from Siemens Healthineers, which is addressing staffing challenges in clinical laboratories, and Inflammatix’s upcoming launch, poised to revolutionize sepsis diagnostics. Plus, we spoke with the President of Beckman Coulter Diagnostics about their role in driving a new era of innovation, with BioDot about its leadership in precision dispensing technology, and many more manufacturers leading the field of clinical diagnostics.

We also introduced our exciting new initiative, CLINICAL24, which focuses on the challenges faced by clinical laboratory scientists and how emerging technologies are helping to overcome these obstacles.

This video was filmed at ADLM 2024.

About the company

SelectScience logo

SelectScience

Established in July 1998, SelectScience is the fastest way to impartial, expert opinion about the best laboratory equipment and latest techniques.

Other videos from SelectScience

Links

Tags

SepsisSepsis is a life-threatening response to infection causing organ dysfunction. Research focuses on early detection, biomarkers, and therapies to reduce mortality. Explore tools for sepsis diagnostics and analysis in our peer-reviewed product directory, including detection kits and biomarkers.Molecular DiagnosticsMolecular diagnostics use an individual’s genetic code and gene expression to diagnose and monitor diseases. The technique is used increasingly in the field of infectious diseases and oncology, as well as areas such as coagulation, HLA typing and pharmacogenomics. Molecular diagnostics plays a pivotal role in personalized medicine.Clinical DiagnosticsLab InnovationsHematology SolutionsHematology solutions involve diagnostic tests and equipment used to analyze blood samples and diagnose blood disorders such as anemia, leukemia, and hemophilia. These tools include automated full blood count analyzers, reagents, and digital morphology systems. Explore hematology solutions in our peer-reviewed product directory; compare products, check reviews, and get pricing directly from manufacturers.Assay DevelopmentThe process of proving an assay to be sensitive with respect to the target is known as assay development. The assay should be able to characterize novel compounds and measure the potency of these compounds against a validated biological target.